19th May 2016 15:49
LONDON (Alliance News) - Sinclair Pharma PLC on Thursday said it has signed a four-year, exclusive distribution and strategic marketing agreement with Thermigen LLC for Silouhette Instalift.
Sinclair added it has regained distribution rights for Silouhette Soft in Brazil, saying the two deals will make the company well-positioned to deliver long-term growth.
Sinclair said it has granted Thermigen a four-year distribution licence for the US market, running to mid-2020. Silouhette Soft will be combined with Thermigen's ThermiTight skin laxity treatment in order to provide patients with a minimally-invasive, non-surgical alternative to a face lift.
Under the deal, Sinclair has granted Thermigen an exclusive four-year distribution deal for the US market, involving in the launch and marketing of Silouhette Instalift by Sinclair.
"We are delighted to announce our collaboration with Thermi who have recognised the significant potential of Silhouette InstaLift," said Sinclair Chief Executive Chris Spooner.
Sinclair shares closed down 1.5% to 32.50 pence.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Sinclair Pharma